RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dynavax Technologies Stock

Dynavax Technologies ROA 2024

Dynavax Technologies ROA

-0.01

Ticker

DVAX

ISIN

US2681582019

WKN

A12EV9

In 2024, Dynavax Technologies's return on assets (ROA) was -0.01, a -102.16% increase from the 0.3 ROA in the previous year.

Dynavax Technologies Aktienanalyse

What does Dynavax Technologies do?

Dynavax Technologies Corp is a US-based biotechnology company that specializes in developing innovative therapies and vaccines to combat infectious diseases and cancer. The company was founded in 1996 and is headquartered in Emeryville, California. Dynavax's roots can be traced back to the research work of Dr. Lawrence Steinman, a renowned immunologist at Stanford University. The company initially focused on researching autoimmune diseases such as multiple sclerosis and arthritis. In 2001, Dynavax received approval from the US Food and Drug Administration (FDA) for their first developed product called HEPLISAV, a hepatitis B vaccine. The company's business model is based on researching and developing therapies and vaccines based on immunology and genetics. Dynavax conducts intensive research in its laboratories to develop new treatment approaches and vaccines. The company collaborates closely with universities, government institutions, and other biotechnology companies to test and verify the effectiveness and safety of its products. Dynavax is divided into several divisions to oversee its product development and distribution activities. These divisions include vaccines, oncology, and autoimmune diseases. Dynavax has introduced several products to the market in recent years, including HEPLISAV, SD-101, AZD1419, and DYVAX FQ. The company continues to focus on researching and developing new therapies and vaccines. Dynavax Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Dynavax Technologies's Return on Assets (ROA)

Dynavax Technologies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Dynavax Technologies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Dynavax Technologies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Dynavax Technologies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Dynavax Technologies stock

What is the Return on Assets (ROA) of Dynavax Technologies this year?

The Return on Assets (ROA) of Dynavax Technologies is -0.01 undefined this year.

What was the ROA of Dynavax Technologies compared to the previous year?

The ROA of Dynavax Technologies has increased by -102.16% compared to the previous year.

What consequences do high ROA have for investors of Dynavax Technologies?

A high ROA is advantageous for investors of Dynavax Technologies, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Dynavax Technologies?

A low ROA can be unfavorable for investors of Dynavax Technologies as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Dynavax Technologies affect the company?

An increase in ROA of Dynavax Technologies can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Dynavax Technologies impact the company?

A reduction in the ROA of Dynavax Technologies can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Dynavax Technologies?

Some factors that can influence the ROA of Dynavax Technologies include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Dynavax Technologies important for investors?

The ROA of Dynavax Technologies is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Dynavax Technologies take to improve ROA?

To improve ROA, Dynavax Technologies can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Dynavax Technologies pay?

Over the past 12 months, Dynavax Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dynavax Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Dynavax Technologies?

The current dividend yield of Dynavax Technologies is .

When does Dynavax Technologies pay dividends?

Dynavax Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dynavax Technologies?

Dynavax Technologies paid dividends every year for the past 0 years.

What is the dividend of Dynavax Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dynavax Technologies located?

Dynavax Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dynavax Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dynavax Technologies from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did Dynavax Technologies pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of Dynavax Technologies in the year 2023?

In the year 2023, Dynavax Technologies distributed 0 USD as dividends.

In which currency does Dynavax Technologies pay out the dividend?

The dividends of Dynavax Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dynavax Technologies

Our stock analysis for Dynavax Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dynavax Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.